The Human T-Cell Leukemia Virus Type 1 Basic Leucine Zipper Factor Attenuates Repair of Double-Stranded DNA Breaks via Nonhomologous End Joining

Journal of Virology
Amanda W RushingIsabelle Lemasson

Abstract

Adult T-cell leukemia (ATL) is a fatal malignancy of CD4+ T cells infected with human T-cell leukemia virus type 1 (HTLV-1). ATL cells often exhibit random gross chromosomal rearrangements that are associated with the induction and improper repair of double-stranded DNA breaks (DSBs). The viral oncoprotein Tax has been reported to impair DSB repair but has not been shown to be consistently expressed throughout all phases of infection. The viral oncoprotein HTLV-1 basic leucine zipper (bZIP) factor (HBZ) is consistently expressed prior to and throughout disease progression, but it is unclear whether it also influences DSB repair. We report that HBZ attenuates DSB repair by nonhomologous end joining (NHEJ), in a manner dependent upon the bZIP domain. HBZ was found to interact with two vital members of the NHEJ core machinery, Ku70 and Ku80, and to be recruited to DSBs in a bZIP-dependent manner in vitro We observed that HBZ expression also resulted in a bZIP-dependent delay in DNA protein kinase (DNA-PK) activation following treatment with etoposide. Although Tax is reported to interact with Ku70, we did not find Tax expression to interfere with HBZ:Ku complex formation. However, as Tax was reported to saturate NHEJ, we found tha...Continue Reading

References

Mar 1, 1989·Japanese Journal of Cancer Research : Gann·T OkamotoK Shimotohno
Dec 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·B J PoieszR C Gallo
Apr 19, 1996·The Journal of Biological Chemistry·O J SemmesK T Jeang
Feb 23, 1999·Biochemistry·D W ChanS P Lees-Miller
Mar 19, 1999·Molecular and Cellular Biology·P Labhart
Oct 29, 1999·Genes & Development·A J PierceM Jasin
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·S WangG C Li
Mar 10, 2001·Nature Genetics·K K Khanna, S P Jackson
May 18, 2001·Nature·J H Hoeijmakers
Jul 4, 2001·The Journal of Biological Chemistry·F J Lemoine, S J Marriott
Mar 22, 2002·Journal of Virology·Min-Hui LiangChou-Zen Giam
Sep 3, 2003·Nature Reviews. Cancer·Oliver M SieberIan P M Tomlinson
Jan 22, 2004·Proceedings of the National Academy of Sciences of the United States of America·Thomas WechslerMatthias Wabl
Mar 3, 2004·International Journal of Cancer. Journal International Du Cancer·Satoshi TakedaMasao Matsuoka
Mar 27, 2004·FEBS Letters·Sabine ThébaultJean-Michel Mesnard
May 5, 2004·Mutagenesis·Rinne De Bont, Nik van Larebeke
Jun 15, 2004·The Journal of Biological Chemistry·Yu-Gang WangKaren M Frank
Jul 29, 2004·DNA Repair·Sandeep Burma, David J Chen
Aug 18, 2004·Retrovirology·Inbal AzranMordechai Aboud
Jan 29, 2005·The Journal of Biological Chemistry·Benjamin P C ChenDavid J Chen
Mar 4, 2005·Retrovirology·Kiyoshi Takatsuki
Mar 10, 2005·Journal of Cell Science·Patrick HivinJean-Michel Mesnard
Mar 29, 2005·The Journal of Biological Chemistry·Sivanandhan DhanalakshmiRajesh Agarwal
Aug 12, 2005·The Journal of Biological Chemistry·Yunmei MaMichael R Lieber
Sep 13, 2005·Oncogene·Susan J Marriott, Oliver John Semmes
Dec 7, 2005·The Journal of Cell Biology·Michela Di Virgilio, Jean Gautier
Jan 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yorifumi SatouMasao Matsuoka
Mar 4, 2006·Retrovirology·Marie-Hélène CavanaghBenoit Barbeau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.